[
    "{\"step_by_step_thinking\": \"MAGE-A3 is a tumor-specific antigen that is expressed in a variety of cancers, including non-small-cell lung cancer. An immunotherapeutic targeting MAGE-A3 was developed and tested in clinical trials. However, the phase III clinical trials did not show a significant survival benefit for patients with MAGE-A3-positive non-small-cell lung cancer. Therefore, it is not considered effective.\", \"answer_choice\": \"B\"}"
]